Cargando…

A52 GUT-INNERVATING TRPV1+ NEURONS DRIVE CHRONIC VISCERAL PAIN VIA MICROGLIAL P2Y12 RECEPTOR

BACKGROUND: Long-lasting changes in neural pain circuits precipitate the transition from acute to chronic pain in patients living with inflammatory bowel diseases (IBDs). While significant improvement in IBD therapy has been made to reduce inflammation, a large subset of patients continues to suffer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Defaye, M, Abdullah, N, Iftinca, M, Hassan, A, Agosti, F, Zhang, Z, Cumenal, M, Zamponi, G W, Altier, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Poster of Distinction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859394/ http://dx.doi.org/10.1093/jcag/gwab049.051

Ejemplares similares

Gut-innervating TRPV1+ Neurons Drive Chronic Visceral Pain via Microglial P2Y12 Receptor
por: Defaye, Manon, et al.
Publicado: (2021)

A230 THE ROLE OF THE MICROBIOTA IN NOCICEPTOR DEVELOPMENT AND PAIN SENSITIVITY
por: Abdullah, N, et al.
Publicado: (2022)

A52 SEX DIFFERENCES IN POST-INFLAMMATORY VISCERAL PAIN IN A MOUSE MODEL OF INFLAMMATORY BOWEL DISEASE (IBD)
por: Arzamendi, M, et al.
Publicado: (2023)

A36 NON-PSYCHOTROPIC PHYTOCANNABINOIDS ATTENUATE VISCERAL HYPERSENSITIVITY IN DEXTRAN SULFATE SODIUM (DSS)-INDUCED COLITIS
por: Svendsen, K, et al.
Publicado: (2022)

TRPV1 Activation Promotes β-arrestin2 Interaction with the Ribosomal Biogenesis Machinery in the Nucleolus: Implications for p53 Regulation and Neurite Outgrowth
por: Hassan, Ahmed, et al.
Publicado: (2021)

The neuronal tyrosine kinase receptor ligand ALKAL2 mediates persistent pain
por: Defaye, Manon, et al.
Publicado: (2022)

A37 EFFICACY AND SAFETY OF RISANKIZUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH CROHN’S DISEASE: 52 WEEK RESULTS FROM THE PHASE 3 FORTIFY STUDY
por: Panaccione, R, et al.
Publicado: (2022)

pHluorin-tagged TRPV1 shines light on capsaicin tachyphylaxis
por: Agosti, Francina, et al.
Publicado: (2019)

A238 ALTERED GUT MICROBIOME COMPOSITION AND FUNCTION ARE ASSOCIATED WITH GUT BARRIER DYSFUNCTION IN HEALTHY RELATIVES OF CROHN’S DISEASE PATIENTS
por: Leibovitzh, H, et al.
Publicado: (2022)

A46 BIOGEOGRAPHIC VARIATION AND FUNCTIONAL PATHWAYS OF THE GUT MICROBIOTA IN CELIAC DISEASE
por: Libertucci, J, et al.
Publicado: (2022)

A51 ROLE OF GUT MICROBIOTA IN THE EPISODIC NATURE OF SYMPTOMS IN IRRITABLE BOWEL SYNDROME
por: Mohan, V, et al.
Publicado: (2022)

A77 IMPLEMENTATION OF GUT LINK-IBS; RESULTS OF A SEMI-STRUCTURED INTERVIEW OF PRIMARY CARE PROVIDERS
por: Sharma, S, et al.
Publicado: (2022)

A46 ENTEROBACTERIACEAE ENRICHMENT IN THE GUT MICROBIOME OF CRITICALLY ILL PATIENTS PROMOTES IMMUNE DYSFUNCTION AND SUSCEPTIBILITY TO NOSOCOMIAL INFECTIONS
por: Schlechte, J M, et al.
Publicado: (2023)

A199 UTILIZATION OF MUCUS-DERIVED O-GLYCAN SUGARS BY THE PATHOGEN C. RODENTIUM FACILITATE ITS COLONIZATION OF THE MURINE GUT
por: Mslati, M, et al.
Publicado: (2022)

A47 THE GUT MICROBIOTA INFLUENCES COLONIC HEALING AFTER SURGERY IN PATIENTS UNDERGOING BOWEL RESECTION FOR COLORECTAL CANCER
por: Hajjar, R, et al.
Publicado: (2023)

A234 IN VITRO GUT MICROBIOME AND METABOLITE RESPONSES TO RESISTANT STARCH ARE INDIVIDUALIZED
por: Dobranowski, P, et al.
Publicado: (2022)

A231 COLORECTAL CANCER PROVINCIAL SCREENING OPTIMIZATION USING GUT MICROBIOME AS BIOMARKER
por: Laforest-Lapointe, I
Publicado: (2022)

A55 INTERLEUKIN-10 ELICITS CYTOPROTECTION VIA MITOCHONDRIAL SIGNAL TRANSDUCER AND ACTIVATORS OF TRANSCRIPTION 3 (MTSTAT3) TO PREVENT BACTERIAL PATHOBIONT EVOKED MITOCHONDRIAL FRAGMENTATION IN GUT EPITHELIA
por: NavaneethaKrishnan, S, et al.
Publicado: (2022)

Mutations in calmodulin-binding domains of TRPV4/6 channels confer invasive properties to colon adenocarcinoma cells
por: Arbabian, Atousa, et al.
Publicado: (2020)

A40 GUT MICROBIOTA PROMOTES NUTRIENT AVAILABLITY AND PATHOGENESIS OF AN ATTACHING/ EFFACING BACTERIAL PATHOGEN
por: Liang, Q, et al.
Publicado: (2023)

A157 DEFINITIONS OF MEDITERRANEAN DIET INCONSISTENTLY ASSOCIATE WITH MARKERS OF GUT BARRIER FUNCTION OR SUBCLINICAL INFLAMMATION IN A POPULATION-BASED COHORT
por: Neustaeter, A, et al.
Publicado: (2022)

A171 EXPLORING PATIENT PERSPECTIVES ON A 12-WEEK, ONLINE STRESS REDUCTION INTERVENTION IN INFLAMMATORY BOWEL DISEASE
por: Hyde, A, et al.
Publicado: (2022)

The stress protein heat shock cognate 70 (Hsc70) inhibits the Transient Receptor Potential Vanilloid type 1 (TRPV1) channel
por: Iftinca, Mircea, et al.
Publicado: (2016)

Itch induced by peripheral mu opioid receptors is dependent on TRPV1-expressing neurons and alleviated by channel activation
por: Melo, Helvira, et al.
Publicado: (2018)

PKCε stimulation of TRPV1 orchestrates carotid body responses to asthmakines
por: Jendzjowsky, Nicholas G., et al.
Publicado: (2020)

A86 INFLAMMATORY BOWEL DISEASE PATIENTS’ SATISFACTION WITH TELEHEALTH: DURING THE COVID-19 PANDEMIC
por: Painchaud, M, et al.
Publicado: (2021)

A216 WHEN CANCER CASTS THE FIRST STONE: A CASE REPORT OF GALLBLADDER CANCER PRESENTING AS GALLSTONE ILEUS
por: Shelton, J, et al.
Publicado: (2022)

A224 COVID-19 INFECTION IN LIVER TRANSPLANT RECIPIENTS: CLINICAL FEATURES, HOSPITALIZATION, AND MORTALITY FROM A CANADIAN MULTICENTRE COHORT
por: Smith, M K, et al.
Publicado: (2022)

A183 TELEHEALTH USE IN RURAL SASKATCHEWAN AND INFLAMMATORY BOWEL DISEASE OUTCOMES
por: Patterson, M, et al.
Publicado: (2021)

A25 MEASURING THE OBSERVER (HAWTHORNE) EFFECT ON ADENOMA DETECTION RATES: A CASE-CONTROL RETROSPECTIVE STUDY
por: Taghiakbari, M, et al.
Publicado: (2023)

A134 UES MANOMETRIC PARAMETERS IN ESOPHAGEAL MOTILITY DISORDERS
por: Woo, M, et al.
Publicado: (2022)

A183 SUCCINATE IN THE RELATIONSHIP BETWEEN INFLAMMATORY BOWEL DISEASE AND OBESITY IN SUCCINATE RECEPTOR DEFICIENT MICE
por: Arsenault, A M, et al.
Publicado: (2022)

A27 COMPARATIVE EVALUATION OF THE ABC SCORE TO OTHER RISK STRATIFICATION SCALES IN MANAGING HIGH-RISK PATIENTS PRESENTING WITH ACUTE UPPER GASTROINTESTINAL BLEEDING
por: Barkun, A N, et al.
Publicado: (2022)

A202 IMPACT OF THE COVID-19 PANDEMIC ON THE EPIDEMIOLOGY OF ALCOHOL-RELATED HEPATITIS
por: Frolkis, A, et al.
Publicado: (2022)

A208 ASSESSING FEASIBILITY AND ACCEPTABILITY OF AN ONLINE MIND-BODY WELLNESS PROGRAM FOR PRIMARY BILIARY CHOLANGITIS
por: Watt, M, et al.
Publicado: (2022)

The cool things to know about TRPM8!
por: Iftinca, Mircea, et al.
Publicado: (2020)

A197 ACUTE ILEITIS IN ADULT PATIENT: A RETROSPECTIVE STUDY OF PATIENT OUTCOMES
por: Bachand, M, et al.
Publicado: (2022)

A34 GLUTEN-FREE DIET IMPROVES DYSPEPTIC SYMPTOMS IN PATIENTS WITH TYPE 1 DIABETES IN WHOM CELIAC DISEASE WAS EXCLUDED
por: Miranda, P M, et al.
Publicado: (2022)

A212 LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS (PSC): EXPERIENCE FROM THE LAST THREE DECADES
por: Zhu, J, et al.
Publicado: (2022)

A30 RECURRENCE RATES AFTER ENDOSCOPIC RESECTION OF LARGE COLORECTAL POLYPS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Djinbachian, R, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_btu088c5mkhhskqnl42jejecls